MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and...
MediWound (NASDAQ:MDWD) Stock Passes Below 200-Day Moving Average - Here's Why
Why is Cathie Wood’s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD)
Craig Hallum Forecasts MediWound's Q3 Earnings (NASDAQ:MDWD)
MediWound Q1 Revenue Declines; Reaffirms 2026 Full-Year Guidance; Stock Up
Oversold Conditions For Mediwound (MDWD)
MediWound shares are trading lower after the company reported mixed Q1 financial results.